Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Ipratropium Bromide on Exercise-Induced Laryngeal Obstruction (EILO) in Pediatric Patients

NCT07394036 is registered in ClinicalTrials.gov with Cook Children's Health Care System as lead sponsor.

NCT NCT07394036
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07394036 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Ipratropium Bromide on Exercise-Induced Laryngeal Obstruction (EILO) in Pediatric Patients
Lead sponsor
Cook Children's Health Care System
Phase
Phase 2
Overall status
Not yet recruiting
Start date
June 1, 2026
Completion date
December 31, 2029
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dyspnea during activity, exercise-induced laryngeal obstruction